Tag: Jim Shannon

The below Parliamentary question was asked by Jim Shannon on 2016-04-19.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what discussions he has had with (a) the Russian business community and (b) other Russian citizens living in the UK on Russian attitudes towards the West.

Mr David Lidington

During my visit to Moscow in December 2015, I discussed Russian attitudes towards the West with a group of Russian political commentators. I also meet periodically with the Russian Ambassador to the UK to seek the views of the Russian Government.

Officials at the Foreign and Commonwealth Office and UK Trade and Investment meet Russian individuals and businesses on a regular basis, principally through the Russo-British Chamber of Commerce (RBCC) which celebrates its centenary year in 2016. The UK Government also continues to support the development of cultural and people-to-people links which can help build trust between our two countries, such as through the 2016 UK-Russia Year of Language and Literature.

The below Parliamentary question was asked by Jim Shannon on 2016-05-09.

To ask the Secretary of State for Health, what assessment he has made of the potential contribution of public health nursing to (a) improving the health of the population and preventing acute hospital admissions and (b) delivering the Government’s commitment to seven-day NHS services.

Ben Gummer

Improving population health is the responsibility of every nurse and they have a role in working with individuals, communities and/or the population to prevent illness, protect health and promote wellbeing. The National Health Service Five Year Forward View (FYFV) sets out the need to close the health and wellbeing gap, radically upgrade prevention as part of a drive to reduce acute hospital admissions, and deliver seven-day hospital services for patients with urgent or emergency care needs. The new framework for nurses, midwives and care staff in England, Leading Change, Adding Value, scheduled for publication later this month, sets out how these professionals will support delivery of the FYFV. There are 10 commitments in the framework, of which three specifically relate to population health and population health and prevention.

To support all health care professionals including nurses to provide evidence based preventative interventions and measure their impact, Public Health England will be launching a resource called All Our Health later this month.

The below Parliamentary question was asked by Jim Shannon on 2016-05-19.

To ask the Secretary of State for Health, what steps his Department is taking to reduce the level of student debt among nurses.

Ben Gummer

The Government is currently consulting on its proposed scheme for student finance. As part of that consultation a number of questions are asked about student support. The Government will respond to the consultation in due course.

It is for the respective Governments in Northern Ireland, Scotland and Wales to consider such issues for their health system.

The below Parliamentary question was asked by Jim Shannon on 2016-05-23.

To ask the Secretary of State for Energy and Climate Change, what funding her Department has allocated to help develop clean energy storage.

Andrea Leadsom

Energy storage is one way to provide flexibility to the energy system and to help make best use of our low carbon electricity generation. DECC has provided more than £18m of innovation funding since 2012 for development and demonstration storage technologies; including funding for four storage technology demonstration projects. In the Budget 2016 announcement, the government confirmed that it would allocate at least £50 million to help innovation in energy storage, demand-side response (DSR) and other smart technologies over the next five years.

The below Parliamentary question was asked by Jim Shannon on 2016-06-06.

To ask the Minister for the Cabinet Office, how many reported drink-related violent incidents involved the use of alcohol bottles in each of the last five years.

Mr Rob Wilson

The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

The below Parliamentary question was asked by Jim Shannon on 2016-06-08.

To ask the Secretary of State for Health, what steps he is taking to promote integrated care in the NHS.

Alistair Burt

In 2014, NHS England published the Five Year Forward View, which included an account of five new care models designed to promote integrated service provision. 50 Vanguard sites are currently implementing a new care model, with the support of NHS England and the Department, and with a view to spreading lessons and best practice throughout the health system.

In order to deliver the best outcomes for service users, integration within the National Health Service must be accompanied by integration with social care. The Better Care Fund (BCF), first implemented in 2015/16, is continuing in 2016/17 and requires local government and the NHS to create pooled budgets in every area in England, bringing local leaders and clinical experts together to plan how to spend a portion of their shared resources to provide a more integrated health and care system for local people.

The BCF has laid the foundation for integration across the country, but the Government wants to go further, faster. The Autumn 2016 Spending Review set out the ambition that every area in England should integrate health and social care by 2020, with a plan for this in place by 2017. Achieving better integration within the NHS will be a key element of the broader ambition to integrate across the health and care system as a whole.

The below Parliamentary question was asked by Jim Shannon on 2016-06-09.

To ask the Secretary of State for Health, if he will instruct officials of his Department to continue to work with the manufacturers of Nivolumab on ensuring that patients with non-squamous non-small cell lung cancer can access that drug through the NHS.

George Freeman

The National Institute for Health and Care Excellence (NICE) is currently appraising nivolumab (Opdivo) for non-squamous non-small cell lung cancer.

As part of its appraisal, the NICE has considered a patient access scheme (PAS) proposal from the manufacturer Bristol-Myers Squibb which has been agreed by Ministers. Departmental officials are open to discussing any further proposals regarding the PAS with the company.

The NICE currently expects to publish its final guidance in September 2016.

In the absence of the NICE guidance, it is for commissioners to make funding decisions based on the available evidence.

The below Parliamentary question was asked by Jim Shannon on 2016-06-27.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent reports he has received on the relocation of Bahraini citizenship from Sheikh Isa Qassim.

Mr Tobias Ellwood

We are concerned by reports that the nationality of Bahraini Shia cleric Sheikh Isa Qassim is being revoked, and we have raised these concerns at senior levels in the Bahraini government and publicly. We strongly encourage Bahrain to live up to its international human rights obligations.

The below Parliamentary question was asked by Jim Shannon on 2016-07-07.

To ask the Secretary of State for Environment, Food and Rural Affairs, whether she has had discussions with the Secretary of State for Justice on reviewing sentencing for crimes which involve violence or cruelty against animals.

George Eustice

My officials are in regular dialogue with Ministry of Justice colleagues in relation to sentencing policy with respect to animal cruelty offences including animal fighting.

The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

To ask the Secretary of State for Health, what discussions he has had with his EU counterparts on co-operation on developing and making available new drugs to treat breast cancer.

Nicola Blackwood

Many new medicines in Europe, including medicines to treat breast cancer, are licensed by the European Medicines Agency (EMA). The EMA brings together scientific experts from across Europe by working closely with the national regulatory authorities, in a partnership known as the European medicines regulatory network. The Medicines and Healthcare products Regulatory Agency is an active participant in this network and its discussions.

“